Cochrane · systematic review · CD010256
Intravenous beta₂‐agonists versus intravenous aminophylline for acute asthma
Travers, AH, Jones, AP, Camargo Jr, CA, et al. · Cochrane Database of Systematic Reviews · 2012 · Cochrane Library
AirwaysAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
5
current version
GRADE rated
5
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 1 · 20%Moderate 4 · 80%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
IV beta‐agonists compared to IV aminophylline for acute asthma
Population: patients with acute asthma
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Length of hospital stay IV beta‐agonists vs IV aminophylline | no estimate extracted | 2 studies · 73 participants | Moderate Downgraded: imprecision, inconsistency |
PEF (L/min) at 60 min IV beta‐agonists vs IV aminophylline | no estimate extracted | 2 studies · 59 participants | Moderate Downgraded: imprecision, inconsistency |
FEV1 (L) at 60 min IV beta‐agonists vs IV aminophylline | no estimate extracted | 2 studies · 59 participants | Moderate Downgraded: imprecision, inconsistency |
Heart Rate at 60 min IV beta‐agonists vs IV aminophylline | no estimate extracted | 3 studies · 82 participants | Low Downgraded: imprecision, inconsistency |
Clinical failure4 IV beta‐agonists vs IV aminophylline | no estimate extracted | 2 studies · 89 participants | Moderate Downgraded: imprecision, inconsistency |